Harwin Peter Evan [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
06/14/2023	Viridian Therapeutics, Inc.\DE	MGEN	Grant	Stock Option (Right to Buy)	20k	$27.67	$553.4k	See Footnote	06/14/2023
06/07/2023	Cogent Biosciences, Inc.	UMRX	Grant	Stock Option (Right to Buy)	36.7k	$11.70	$429.4k		06/07/2023
06/08/2022	Viridian Therapeutics, Inc.\DE	MGEN	Grant	Stock Option (Right to Buy)	12.5k	$12.31	$153.9k	See footnote	06/08/2022
06/07/2022	Cogent Biosciences, Inc.	UMRX	Grant	Stock Option (Right to Buy)	30.7k	$4.59	$140.9k		06/07/2022
06/03/2021	Viridian Therapeutics, Inc.\DE	MGEN	Grant	Stock Option (Right to Buy)	12.5k	$16.60	$207.5k		06/03/2021
03/11/2021	Cogent Biosciences, Inc.	UMRX	Grant	Stock Option (Right to Buy)	60k	$8.45	$507k		03/11/2021
02/04/2021	Viridian Therapeutics, Inc.\DE	MGEN	Grant	Director Stock Option (Right to Buy)	25k	$20.50	$512.5k		02/04/2021
10/27/2020	Viridian Therapeutics, Inc.\DE	MGEN	Grant	Director Stock Option (Right to Buy)	24k	$0.52	$12.5k		10/27/2020
08/27/2020	Cogent Biosciences, Inc.	UMRX	Grant	Director Stock Option (Right to Buy)	28.7k	$2.77	$79.4k		08/27/2020